A cell-surface 29-kDa protein (Lam29, cysteine-binding protein of the ABC transporter) from Lactobacillus mucosae ME-340 showed an adhesin-like property for human ABO blood group antigens expressed on the gastrointestinal mucosa. In addition, here we report that Lam29 also bound to an 18-kDa protein on human colonic mucus. By ligand blot assay and N-terminal amino acid sequence of the protein, it was identified as human histone H3. By ligand blot and microplate binding assays with recombinant histone H3, binding between Lam29 and histone H3 was confirmed. The adhesion of ME-340 cells to histone H3 was significantly inhibited by 26% after the addition of 2.5 mg/mL Lam29 as compared to the absence of Lam29 (p < 0:01). By GHCl extraction and transcription attenuation of ME-340 cells, binding reduction of ME340 cells against histone H3 was detected at 12% and 13% respectively, as compared to control cells by the BIACORE assay (p < 0:01). These data indicate that Lam29 shows multiple binding activities to blood group antigens and histone H3 in human colonic mucus. This is the first report to indicate that lactobacilli expressing Lam29 adhere to histone H3 on gastrointestinal mucosa.
A cell-surface 29-kDa protein (Lam29, cysteine-binding protein of the ABC transporter) from Lactobacillus mucosae ME-340 showed an adhesin-like property for human ABO blood group antigens expressed on the gastrointestinal mucosa. In addition, here we report that Lam29 also bound to an 18-kDa protein on human colonic mucus. By ligand blot assay and N-terminal amino acid sequence of the protein, it was identified as human histone H3. By ligand blot and microplate binding assays with recombinant histone H3, binding between Lam29 and histone H3 was confirmed. The adhesion of ME-340 cells to histone H3 was significantly inhibited by 26% after the addition of 2.5 mg/mL Lam29 as compared to the absence of Lam29 (p < 0:01). By GHCl extraction and transcription attenuation of ME-340 cells, binding reduction of ME340 cells against histone H3 was detected at 12% and 13% respectively, as compared to control cells by the BIACORE assay (p < 0:01). These data indicate that Lam29 shows multiple binding activities to blood group antigens and histone H3 in human colonic mucus. This is the first report to indicate that lactobacilli expressing Lam29 adhere to histone H3 on gastrointestinal mucosa.
Key words: adhesion; human colonic mucus; histone H3; ABC transporter; lactobacillus Lactobacilli are often found in the gastrointestinal tract of humans and other animals. [1] [2] [3] [4] Several strains are potential probiotics used commercially in fermented food products. One of the criteria in selecting a probiotic for use in foods is an ability to adhere to the human gastrointestinal tract. Adhesion of lactobacilli to mucosal surfaces in the gastrointestinal tract might play a role in the colonization and subsequent proliferation of bacteria. This possibly promotes modulation of the intestinal immune system and exert inhibitory effects against pathogenic bacteria. 5, 6) In lactobacilli, bacterial cell-surface proteins mediate adherence to the mucosal surfaces in the gastrointestinal tract. Mucus-binding protein (Mub) of Lactobacillus reuteri 1063, 7) the binding of cell-surface associated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Lactobacillus plantarum LA318 to human colonic mucin, 8) and mucus/mucin-binding protein (32-Mmubp) of Lactobacillus fermentum BCS87 9) have been reported. Recently, two pilus gene clusters (spaCBA and spaFED) in the genome of Lactobacillus rhamnosus GG were found, and the SpaB and SpaC subunits in the SpaCBA pilus fiber are involved in binding to the human intestinal mucus. 10, 11) We have reported that Lam29 is an adhesin-like protein from Lactobacillus mucosae ME-340, binding to human blood group A and B antigens expressed on mucosal surfaces.
12) It was identified as a putative cysteine-binding protein of the ATP-binding cassette (ABC) transporter. In addition to the fundamental functions of substrate-binding proteins of ABC transporters in chemoreception and transmembrane transport, it has been suggested that some of the proteins are involved in host-bacteria interactions and act as adhesinlike proteins.
9,13-16) Miyoshi et al. reported that MapA, a putative cysteine-binding protein of the ABC transporter of Lactobacillus reuteri 104R, binds to 90-and 200-kDa receptor-like molecules on Caco-2 cells, and the carbohydrate in the proteins does not mediate bacterial adhesion. 16) Since the function and sequence identity (27%) of Lam29 are like those of MapA, Lam29 might also mediate bacterial adhesion to proteinaceous molecules on the gastrointestinal mucosa. Hence, we investigated Lam29-binding molecules other than blood group antigens expressed on the human gastrointestinal mucosa. Our data would help in understanding the host-bacteria interactions of L. mucosae expressing Lam29 with the mucosal surfaces and colonization of the gastrointestinal tract.
Materials and Methods
Bacterial strains and growth media. Lactobacillus mucosae ME-340 was obtained from the culture collection of Meiji Dairies Corporation (Tokyo, Japan). It was isolated from human feces and identified using the API 50 CHL system (BioMerieux, Marcy I'Etoile, France), and was cultured twice before these experiments at 37 C for 16-24 h in Man Rogosa Sharpe (MRS) broth (Difco Laboratories, Detroit, MI, USA) using 2% (v/v) inoculums.
Carboxyfluorescein diacetate labeling of L. mucosae ME-340 bacterial cells. L. mucosae ME-340 was cultured at 37 C for 24 h in MRS broth and centrifuged (3;000 g, 10 min, RT). The pellet was washed 3 times with distilled water to remove media components. Then it was resuspended in phosphate-buffered saline (PBS, pH 7.4), and 1 mM carboxy-fluorescein diacetate (CFDA) was added. After incubation for 30 min at 37 C in the dark, the CFDA labeled bacterial cells were washed 3 times with distilled water.
Human recombinant histones. Human recombinant histone H3 (H3 subtype, H3.1) expressed in E. coli was purchased from New England Biolabs (Beverly, MA, USA). The protein was dialysed against distilled water at 4 C overnight to remove the dithiothreitol used to prevent oxidation, and was stored at À20 C.
Preparation of bacterial cells and cell-surface proteins. L. mucosae ME-340 was grown for 24 h in MRS broth or MRS supplemented with 0.1% L-cysteine. After incubation, all the bacterial cells were washed 3 times with distilled water and then lyophilized. To prepare bacterial cells and Lam29 protein treated with guanidine hydrochloride (GHCl), the bacterial cells were washed 3 times with phosphate-buffered saline (PBS, pH 7.4) and incubated in 1 M GHCl solution at 37 C for 2 h. After centrifugation (8;500 g, 30 min, 4 C), the pellet of bacterial cells was washed with distilled water and then lyophilized. The supernatant (Lam29 protein) was dialyzed against distilled water and 50 mM TrisHCl buffer (pH 7.5) at 4 C for 24 h. The Lam29 protein in the dialysate was purified by an anion exchange chromatographic procedure, as described below.
Purification of Lam29 from L. mucosae ME-340. Dialysate prepared from L. mucosae ME-340 cells was applied to a DEAEToyopearl 650M column (2:6 Â 40 cm Tosoh, Tokyo, Japan) equilibrated using the same Tris-HCl buffer. The protein was eluted using a linear gradient of NaCl from 0 to 0.6 M in the same buffer. Elution was monitored at 280 nm. The Lam29 protein was detected as a single prominent band of approximately 90% purity using SDS-PAGE (data not shown).
Preparations of human colonic mucus. Crude mucus was obtained by scraping normal intestinal tissues from colorectal cancer patients. The scraped mucus was extracted with chloroform:methanol (2:1, v/v) and diethyl ether to remove lipids. This study was approved by the Ethics Committee of the Tohoku University School of Medicine.
Ligand blot assay. Human colonic mucus (20 mg) was solubilized in SDS buffer (62.5 mM Tris, 2% SDS, 5% -mercaptoehanol, 0.001% bromophenol blue, and 10% glycerol) and heated at 99 C for 20 min. Human recombinant histone H3 (1.3 mg) was solubilized in the same buffer and heated at 99 C for 10 min. The samples were loaded on 15% polyacrylamide gels (SDS-PAGE), and then blotted onto polyvinylidene difluoride (PVDF) membranes (Millipore, Billerica, MA, USA). The membranes were blocked with SuperBlock blocking buffer (Thermo Scientific, Rockford, IL, USA) at room temperature for 1 h and then washed with TBS-T (0.02 M Tris, 0.15 M NaCl, 0.05% Tween 20, pH 8.2). They were incubated with 1 mg/mL biotinylated Lam29 diluted in the same buffer at room temperature for 1 h. After washing 3 times with TBS-T, bound Lam29 was detected by standard immunoblotting techniques.
N-Terminal sequence analysis. Human colonic mucus was electrophoresed by SDS-PAGE and blotted as described above. An 18-kDa protein was excised from the PVDF membrane stained with CBB, and the N-terminal sequence was determined by a Procise ABI 473A sequencer (Applied Biosystems, Tokyo, Japan). A homology search for amino acid sequences was performed using BLAST from the National Center for Biotechnology Information (NCBI).
Western blot assay. The mucus sample was separated by SDS-PAGE, blotted, and blocked with blocking buffer, as described above. The blots were incubated with mouse anti-human histone H3 monoclonal antibody (dilution 1:1,000) (MAB Institute, Kanagawa, Japan) at room temperature for 1 h. After washing with TBS-T, the bound anti-histone H3 antibody was detected standard immunoblotting techniques.
Microplate binding assay. Purified Lam29 and BSA (5 mg/mL) were biotinylated with 15 mL of NHS-X-Biotin (10 mg/mL; Calbiochem, San Diego, CA, USA) in dimethylformamide at 4 C for 2 h, and dialysed against PBS at 4 C overnight. Recombinant human histone H3 (10 mg/mL distilled water, 100 mL per well) was immobilized in 96-well microplates (Thermo Scientific) by incubation at room temperature overnight. The plates were blocked with SuperBlock blocking buffer at room temperature for 1.5 h. As negative control, biotinylated BSA was used. After washing with PBS, serial dilutions of biotinylated Lam29 in PBS supplemented with 0.01% Tween 20 were incubated at room temperature for 1 h. After 3 washes with PBS supplemented with 0.01% Tween 20, they were incubated with extravidin-AP-conjugate (Sigma-Aldrich, St. Louis, MO, USA) at room temperature for 1 h. After washing, the wells were developed with p-nitrophenyl phosphate disodium salt and the absorbance at 405 nm was measured. Measurements were performed in triplicate.
Competitive inhibition assay. After immobilization of recombinant human histone H3, as described above, CFDA-labeled ME-340 cells (5 Â 10 8 cells/mL) were added to the microplate wells together with purified Lam29 (0.05, 0.5, 2.5 mg/mL in 200 mL PBS supplemented with 0.01% Tween 20) . BSA at 2.5 mg/mL was added in 200 mL PBS supplemented with 0.01% Tween 20 as control. ME-340 cells were allowed to adhere at room temperature for 1 h and then were washed 3 times with PBS supplemented with 0.01% Tween 20. ME-340 cells that bound to histone H3 were released and lysed with 1% SDS/0.1 M NaOH, incubated for 1 h at 60 C. This was followed by measurement of fluorescence intensity (Ex: 485 nm, Em: 538 nm) using a Fluoroskan Ascent plate reader (Thermo Fisher Scientific, Waltham, MA, USA).
ABO blood group antigen probe. The following artificially prepared neoglycoprotein was used as blood group A antigen probe: blood group A-trisaccharide bovine serum albumin [GalNAc1-3 (Fuc1-2) Gal-BSA: BSA-A] (Calbiochem).
BIACORE analysis. The interaction of analyte (ME-340 cells) and ligand (human recombinant histone H3 or BSA-A) was evaluated on a biosensor BIACORE 1000 (GE Healthcare Bio-Sciences KK, Tokyo, Japan), which uses quantitative surface plasmon resonance (SPR), as described previously. 17) Histone H3 protein was immobilized on a CM5 research grade chip (GE Healthcare Bio-Sciences KK) using amine coupling following to the manufacturer's instructions. The analyte was suspended (0.1 mg/mL) in HBS-EP buffer (HEPES buffered saline with EDTA and polysorbate 20: 0.01 M HEPES, pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% surfactant P20; GE Healthcare Bio-Sciences KK) and injected at a flow rate of 3 mL/min at 25 C for 5 min. After washing with HBS-EP buffer to remove unbound analyte, the resonance units (RUs) were measured for 180 s after cessation of Lam29 addition. The ligand immobilized on the sensor chip was regenerated by elution with 0.5-3 M GHCl solution at a flow rate of 3 mL/min for 2 min. A response of 1 RU represents a weight change of 1 pg/mm 2 analyte bound to the sensor chip surface.
Statistics. All experiments were performed in triplicate and are reported as mean AE SD. For the microplate assay and the BIACORE assay, statistical analysis of data was performed by one-way analysis of variance (ANOVA), followed by post hoc Dunnet test when the F value showed significant differences at p < 0:05. For every statistic, significant differences were a p-value < 0.05.
Results

Detection of the Lam29-binding molecules in human colonic mucus
To investigate the receptor-like molecules in human colonic mucus for Lam29 from Lactobacillus mucosae ME-340, ligand blot assay using biotinylated Lam29 was performed. A prominent band at 18 kDa was detected in proteins from human colonic mucus visualized after Coomassie Brilliant Blue staining (Fig. 1a, b) . There was also some binding with the proteins at 31 kDa. We focused on the 18-kDa major protein.
The 18-kDa protein was electrically transferred to a PVDF membrane, and then we sequenced the Nterminal amino acids. Twelve amino acid residues were identified: NH 2 -ARTKQTARKSTG. A comparison of the sequence to the database showed 100% identity with human histones H3.1, H3.2, and H3.3. The anti-human histone H3 monoclonal antibody reacted only with the 18-kDa protein on western blot suggesting that the presence of histone H3 in human colonic mucus (Fig. 1c) .
Binding of Lam29 to recombinant histone H3 protein
To verify the binding activities of Lam29 to histone H3, ligand blot assay using human recombinant histone H3 was performed. Lam29 bound to the recombinant protein, confirming that the previously described Lam29-binding molecules were histone H3 (Fig. 2a) . The binding of Lam29 to histone H3 was dose-dependent, as confirmed by the microplate binding assay (Fig. 2b) . In contrast, BSA showed no binding to histone H3.
Competitive inhibition assay
To determine the role of Lam29 in the adhesion of ME-340 cells to histone H3, an inhibition assay with Lam29 was performed. Lam29 was found to reduce the adhesion of CFDA-labeled ME-340 cells to histone H3 in a dose-dependent manner, and the adhesion of ME-340 cells with 2.5 mg/mL Lam29 was significantly reduced by 26%, as compared to the absence of Lam29 (p < 0:01) (Fig. 3) . This indicates that Lam29 contributes to the adhesion of ME-340 cells to histone H3.
The role of Lam29 in ME-340 bacterial adhesion to histone H3
Our data, as above, suggest that a decrease in Lam29 on the ME-340 cell surface reduces bacterial adherence. Expression of the cysteine-binding protein in the ABC transporter was regulated by a transcription attenuation mechanism, and can be decreased by incubation in the presence of L-cysteine, as found for MapA from L. reuteri 104R. 18) To determine whether Lam29 is essential for bacterial adhesion, we used Lam29-decreased bacterial cells and measured the binding of the bacterial cells to histone H3, as compared to the control cells. The level of Lam29 proteins treated with 1 M GHCl solution was highly (approximately 90%) reduced by incubation in MRS broth supplemented with 0.1% L-cysteine, suggesting that the decrease of Lam29 in bacterial surface (Fig. 4a) . The control ME-340 cells adhered to histone H3 at 318:6 AE 3:2 RU (highest RU, 321.8), whereas a significant (13%) decrease was detected with Lam29-decreased cells to histone H3 at 275:8 AE 8:2 RU (highest RU, 284.7) by BIACORE assay (p < 0:01) (Fig. 4b) . In addition, the GHCltreated ME-340 cells also showed binding capacity for histone H3 at 281:1 AE 8:2 RU (highest RU, 290.6), suggesting that Lam29 is involved in the adhesion of ME-340 cells to histone H3, although a decrease in and the removal of Lam29 had a little effect on the binding of the cells to histone H3. In contrast, the adhesion of Lam29-decreased cells and GHCl-treated ME-340 cells to BSA-A showed greater reductions of 57% and 59% respectively, as compared to the control cells (p < 0:01) (Fig. 4c) .
Discussion
We have reported that Lam29 is an adhesin-like protein from ME-340, binding blood group A and B antigens expressed on mucosal surfaces, and Lam29 has been identified as a putative cysteine-binding protein of the ABC transporter. 12) In the present study, we focused on proteinaceous components other than blood group antigens on human colonic mucus as receptor-like molecules for Lam29.
By ligand blot assay, an 18-kDa protein in human colonic mucus was found, and it was identified as histone H3 by N-terminal sequence analysis. The protein was also detected by Western blot using the anti-histone H3 antibody, suggesting that histone H3 was in the intestinal mucus. Histones were originally known as nuclear proteins, and they play important roles in transcriptional regulation. 19) In a recent study, however, histones were found at the cell surface on monocytes, lymphocytes, and epithelial cells. [20] [21] [22] [23] Rose et al. reported that detached villus epithelial cells released histone H1 into the intestinal lumen by rapid turnover and found it had antimicrobial activity against microorganisms. 24) The mucosal surfaces of the human intestine contain negatively charged molecules, including sialic acid and sulfate groups. 25, 26) Hence, it was suggested that extracellular histones released from the cells by apoptosis bind to the negatively charged surfaces of adjacent viable cells. 27) We detected histone H3 in human colonic mucus, indicating highly basic histones other than histone H1 would also be released into the lumen from intestinal epithelial cells and localized on the mucosal surfaces by electrostatic interaction.
In ligand blot assay of the intestinal mucus, Lam29 also bound to a 31-kDa protein corresponding to the migration position on SDS-PAGE of histone H1. Adhesion of Lam29 to recombinant histone H1, H2A, and H2B was detected by ligand blot assay (Watanabe, unpublished results) . This suggests that the binding of Lam29 to the 31-kDa proteins was due to the presence of histone H1. Further study is needed to identify these histones and to clarify the interaction with Lam29 on mucosal surfaces in the human gastrointestinal tract.
Lam29 also bound recombinant histone H3 in a dosedependent manner on microplate binding assay. Since the strongly cationic properties of Lam29 (pI: 9.9) resemble histone H3 (pI: 11.1), it is likely that electrostatic repulsion between equally charged surfaces is dominant. However, binding assay at various NaCl concentrations up to 2 M indicated stronger binding between Lam29 and histone H3 in low ionic strength NaCl rather than in high ionic strength NaCl (Watanabe, unpublished results). The data indicate that the binding of Lam29 to histone H3 is mediated through electrostatic interaction, and that the overall positive charge of Lam29 dominates the interactions between oppositely charged, localized sites on the interacting surfaces.
We found that ME-340 cells adhered to histone H3 by microplate binding assay. Although adherence between ME-340 cells and histone H3 was inhibited by the addition of Lam29 in a dose-dependent manner, threefourths of the ME-340 cells bound to histone H3. In addition, the decrease in adhesion of the Lam29-decreased and GHCl-treated ME-340 cells to histone H3 was only 10% as compared to the control cells by BIACORE assay. These data suggest that Lam29 was the adhesion factor on ME-340 cells, but adhesin-like proteins other than Lam29 and/or alternative adhesionlike proteins exposed by a decrease in and the removal of Lam29 on the cell surface may be involved in the adhesion of the cells to histone H3. In fact, it has been reported that L. mucosae strains possess a Mub-derived gene involved in adhesion to mucin and in colonization of the gastrointestinal tract. 28) Other adhesion factors and their binding specificities to receptors are currently under investigation.
By BIACORE assay, a higher decrease in ME-340 cell adhesion to blood group antigen A than to histone H3 was shown at 60%. These data suggest that Lam29 is involved in ME-340 cell adhesion to blood group antigens rather than histone H3 and that Histone H3 plays supplemental roles in ME-340 cell adhesion mediated by Lam29.
With pathogenic bacteria, two methods of exploiting histone and histone-like proteins have been reported: as adhesion factors of pathogenic bacteria and the receptor of host. In the former case, the binding of surfaceassociated histone-like protein (HlpA) from Streptococcus gallolyticus to colon adenocarcinoma cells 29) and the binding of Hlp/LBP from Mycobacterium leprae to the extracellular matrix, 30) and in the latter case, the adhesion of 987P fimbriae from enterotoxigenic E. coli to histone H1 receptor 23) were reported. This indicates that histone proteins may be important factors in establishing infections by pathogenic bacteria in the human gastrointestinal tract. Because L. mucosae ME-340 adheres to the same histone proteins, the strain could competitively and directly inhibit infection with these pathogens, and should be useful in probiotic foods.
In this study, we investigated Lam29-binding molecules other than blood group antigens in the gastrointestinal mucosa and identified them as histone H3. We confirmed the binding capacity of purified Lam29 for recombinant histone H3 and the involvement of Lam29 in L. mucosae ME-340 adhesion to histone H3. The multiple binding activities of Lam29 to blood group antigens and histone H3 should be helpful for the initial colonization and later proliferation of L. mucosae ME-340. However, the adhesion of ME-340 cells to human colonic mucin or mucus through Lam29-histone H3 interactions remains to be determined. Further study will be needed to understand the importance of L. mucosae ME-340 adhesion to histone H3 mediated by Lam29 in the gastrointestinal mucosa.
